Home » Making Sense of FDA's Risk-Based Initiative

Making Sense of FDA's Risk-Based Initiative

Overview:

Here's a no-nonsense three-page overview of FDA's 21st Century cGMP guidelines, written by attorney Patricia J. Kaeding, formerly of FDA's Office of Chief Counsel.

More content on this topic:

  • Featured White Papers